Folgen
Maria Casadellà
Maria Casadellà
IrsiCaixa AIDS Research Institute
Bestätigte E-Mail-Adresse bei irsicaixa.es
Titel
Zitiert von
Zitiert von
Jahr
Gut microbiota linked to sexual preference and HIV infection
M Noguera-Julian, M Rocafort, Y Guillén, J Rivera, M Casadellà, P Nowak, ...
EBioMedicine 5, 135-146, 2016
3822016
Primary resistance to integrase strand-transfer inhibitors in Europe
M Casadellà, PM Van Ham, M Noguera-Julian, A vAn Kessel, C Pou, ...
Journal of antimicrobial chemotherapy 70 (10), 2885-2888, 2015
812015
Evolution of the gut microbiome following acute HIV-1 infection
M Rocafort, M Noguera-Julian, J Rivera, L Pastor, Y Guillén, J Langhorst, ...
Microbiome 7, 1-17, 2019
762019
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial
JL Blanco, J Rojas, R Paredes, E Negredo, J Mallolas, M Casadella, ...
Journal of Antimicrobial Chemotherapy 73 (7), 1965-1971, 2018
732018
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study
SC Inzaule, RL Hamers, M Noguera-Julian, M Casadellà, M Parera, ...
The Lancet HIV 5 (11), e638-e646, 2018
682018
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection
Y Guillén, M Noguera-Julian, J Rivera, M Casadellà, AS Zevin, M Rocafort, ...
Mucosal immunology 12 (1), 232-246, 2019
652019
Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa
SC Inzaule, RL Hamers, M Noguera-Julian, M Casadellà, M Parera, ...
Journal of Antimicrobial Chemotherapy 73 (5), 1167-1172, 2018
622018
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing
ER Lee, N Parkin, C Jennings, CJ Brumme, E Enns, M Casadellà, ...
Scientific Reports 10 (1), 1634, 2020
582020
Deep sequencing for HIV-1 clinical management
M Casadellà, R Paredes
Virus research 239, 69-81, 2017
552017
Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing
C Pou, M Noguera-Julian, S Pérez-Álvarez, F García, R Delgado, ...
Clinical infectious diseases 59 (4), 578-588, 2014
552014
Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial
A Bonjoch, C Pou, N Pérez-Alvarez, R Bellido, M Casadella, J Puig, ...
Journal of Antimicrobial Chemotherapy 68 (6), 1382-1387, 2013
352013
Gut microbiota linked to sexual preference and HIV infection. EBioMedicine 5: 135–146
M Noguera-Julian, M Rocafort, Y Guillén, J Rivera, M Casadellà, P Nowak, ...
342016
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
L Bailón, A Llano, S Cedeño, T Escribà, M Rosás-Umbert, M Parera, ...
Nature Medicine 28 (12), 2611-2621, 2022
252022
Yaws re-emergence and bacterial drug resistance selection after mass administration of azithromycin: a genomic epidemiology investigation
MA Beale, M Noguera-Julian, C Godornes, M Casadellà, ...
The Lancet Microbe 1 (6), e263-e271, 2020
212020
Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing
M Casadellà, M Noguera-Julian, H Sunpath, M Gordon, C Rodriguez, ...
Aids 30 (7), 1137-1140, 2016
212016
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
A Borgognone, M Noguera-Julian, B Oriol, L Noël-Romas, M Ruiz-Riol, ...
Microbiome 10 (1), 59, 2022
192022
No detection of the NS5B S282T mutation in treatment-naive genotype 1 HCV/HIV-1 coinfected patients using deep sequencing
S Franco, M Casadellà, M Noguera-Julian, B Clotet, C Tural, R Paredes, ...
Journal of clinical virology 58 (4), 726-729, 2013
192013
HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32
E Ballana, E Riveira-Munoz, C Pou, V Bach, M Parera, M Noguera, ...
Immunobiology 218 (4), 543-547, 2013
162013
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant
C Beltran-Pavez, CB Ferreira, A Merino-Mansilla, A Fabra-Garcia, ...
PLoS One 13 (12), e0208345, 2018
112018
Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease
M Casadella, C Manzardo, M Noguera-Julian, E Ferrer, P Domingo, ...
Aids 29 (12), 1493-1504, 2015
112015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20